HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bence Kapuvári Selected Research

gonadotropin-releasing hormone-III

9/2019Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice.
1/2016Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice.
12/2015[Studying the tumor growth inhibitory effect of modified GnRH-III-anthracycline bioconjugates in subcutaneous vs. orthotopic models in vivo].
1/2012In-vivo antitumour effect of daunorubicin-GnRH-III derivative conjugates on colon carcinoma-bearing mice.
4/2009Development of an oxime bond containing daunorubicin-gonadotropin-releasing hormone-III conjugate as a potential anticancer drug.
4/2007Structure, enzymatic stability and antitumor activity of sea lamprey GnRH-III and its dimer derivatives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bence Kapuvári Research Topics

Disease

9Neoplasms (Cancer)
09/2019 - 04/2007
4Colonic Neoplasms (Colon Cancer)
09/2019 - 04/2009
2Breast Neoplasms (Breast Cancer)
09/2019 - 01/2015
2Colorectal Neoplasms (Colorectal Cancer)
09/2019 - 01/2016
2Body Weight (Weight, Body)
01/2012 - 04/2009
1Tics (Tic)
09/2019
1Neoplasm Metastasis (Metastasis)
09/2019
1Squamous Cell Carcinoma of Head and Neck
01/2019
1Ductal Carcinoma
01/2015
1Carcinoma (Carcinomatosis)
01/2012
1Prostatic Neoplasms (Prostate Cancer)
07/2011

Drug/Important Bio-Agent (IBA)

6gonadotropin-releasing hormone-IIIIBA
09/2019 - 04/2007
4Daunorubicin (Cerubidine)FDA LinkGeneric
09/2019 - 04/2009
4Pharmaceutical PreparationsIBA
09/2019 - 04/2009
3Cytostatic AgentsIBA
12/2015 - 04/2009
2LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2019 - 01/2016
2Peptides (Polypeptides)IBA
08/2019 - 01/2016
2Hormones (Hormone)IBA
01/2016 - 01/2015
2OximesIBA
01/2016 - 01/2012
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2019
1Biological ProductsIBA
09/2019
1Cetuximab (Erbitux)FDA Link
01/2019
1Peroxidase (Myeloperoxidase)IBA
01/2019
1ParaffinIBA
01/2019
1Lysosomal Membrane ProteinsIBA
01/2019
1Butyric Acid (Butanoic Acid)IBA
01/2016
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2016
1Peptide Hormones (Polypeptide Hormones)IBA
12/2015
1AnthracyclinesIBA
12/2015
1Progesterone Receptors (Progesterone Receptor)IBA
01/2015
1SteroidsIBA
01/2015
1human ERBB2 proteinIBA
01/2015
1estrone sulfate (Evex)FDA Link
01/2015
1Estrogen ReceptorsIBA
01/2015
1Androstenedione (4 Androstene 3,17 dione)IBA
01/2015
1EstroneFDA Link
01/2015
1thiazolyl blueIBA
07/2011
1Doxorubicin (Adriamycin)FDA LinkGeneric
04/2009
1lysylprolineIBA
04/2007
1seryl-histidineIBA
04/2007

Therapy/Procedure

4Therapeutics
09/2019 - 12/2015
2Drug Therapy (Chemotherapy)
01/2016 - 01/2012
1Induction Chemotherapy
01/2019
1Transplantation
04/2009